Intralesional Injection of Acyclovir Versus Candida Antigen in Treatment of Plantar Warts
Condition(s):Acyclovir and Candida Antigen in Treatment of Plantar WartLast Updated:June 23, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Acyclovir and Candida Antigen in Treatment of Plantar WartLast Updated:June 23, 2022Recruiting
Condition(s):Plantar WartLast Updated:April 13, 2022Not yet recruiting
Condition(s):Herpesviridae Infections; Herpes Simplex 1; Varicella Zoster Virus Infection; Transplantation Infection; OncologyLast Updated:January 20, 2022Active, not recruiting
Condition(s):Drug UseLast Updated:August 3, 2021Completed
Condition(s):Molluscum ContagiosumLast Updated:July 20, 2020Recruiting
Condition(s):Ulcers of Female Genital OrgansLast Updated:September 15, 2017Completed
Condition(s):Genital HerpesLast Updated:March 22, 2012Completed
Condition(s):Dermatologic DisordersLast Updated:March 17, 2016Completed
Condition(s):UveitisLast Updated:April 5, 2021Recruiting
Condition(s):HSV Infection; HIV InfectionLast Updated:April 8, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.